Take it with a grain of salt....but this quote fro

Quote:

---

Pourhassan closed with a personal story about the impact leronlimab has had on someone in is his own life.

“My own mother-in-law has stage four metastases to her liver, lung, brain , [and she was] given three months to live,” he said. “Now the doctor says if the progress is the same as it is, she could live at least three years, if not more.

“Our animal study indicated a 19-year extension to cancer patients. This is unheard of. [Typically,] with three months extension, a product gets approved. So having this tremendous opportunity is just mind blowing for us.”

---

Quote:

---

Thomas Barnard: So let's see, where shall I begin? How is your mother-in-law? [CytoDyn investors will know that she was the first lady with mTNBC – metastatic triple negative breast cancer – to receive leronlimab.]

Nader Z. Pourhassan, PhD
Nader Pourhassan: Doing much better than she was doing a few weeks ago.

Thomas Barnard: What happened?

Nader Pourhassan: She still has tumor in her brain, and she had a mild stroke a couple of weeks ago. It affected her right side, and the doctor said she would never be able to use the right side, and it won’t come back. But within three days she was able to walk on her own. Slowly, of course. Scott Kelly found published papers on CCR5 and stroke.

Thomas Barnard: What about her right arm? Can she do anything with that?

Nader Pourhassan: Yes, she eats with her right hand, and she’s using it.

Thomas Barnard: Wow.

Nader Pourhassan: Yes, it’s remarkable. We think it is the weekly doses of leronlimab that is helping her. It’s anecdotal, but we are having the doctor prepare a case report.

---